Study Dampens Hope for GLP-1s as Insulin Off-Ramp in Type 2 Diabetes

(MedPage Today) -- Adding a GLP-1 receptor agonist was not associated with a lower likelihood of discontinuing existing basal insulin therapy among veterans with type 2 diabetes compared with other glucose-lowering agents, a target emulation trial...